These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 8313803)

  • 41. Heterogeneity of hepatitis C virus genotypes in France.
    Qu D; Hantz O; Gouy M; Vitvitski L; Li JS; Berby F; Tong SP; Trépo C
    J Gen Virol; 1994 May; 75 ( Pt 5)():1063-70. PubMed ID: 8176368
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatitis C virus genotypes and quantification of serum hepatitis C RNA in liver transplant recipients. Relationship with histologic outcome of recurrent hepatitis C.
    Costes V; Durand L; Pageaux GP; Ducos J; Mondain AM; Picot MC; Domergue J; Larrey D; Baldet P
    Am J Clin Pathol; 1999 Feb; 111(2):252-8. PubMed ID: 9930149
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Use of DNA sequence hybridization with specific oligonucleotide probes to identify hepatitis C virus genotypes].
    Domingo MJ; Fernández I; Lumbreras C; Manzanares J; Morales JM; Noriega AR; Fuertes A
    Enferm Infecc Microbiol Clin; 1996; 14(7):433-5. PubMed ID: 8991438
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hepatitis C superinfection in hepatitis C virus (HCV)-infected patients transplanted with an HCV-infected kidney.
    Widell A; Månsson S; Persson NH; Thysell H; Hermodsson S; Blohme I
    Transplantation; 1995 Oct; 60(7):642-7. PubMed ID: 7570969
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Detection of hepatitis C virus sequences in liver tissue by the polymerase chain reaction.
    Shieh YS; Shim KS; Lampertico P; Balart LA; Jeffers LJ; Thung SN; Regenstein F; Reddy KR; Farr G; Schiff ER
    Lab Invest; 1991 Oct; 65(4):408-11. PubMed ID: 1656140
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical course and risk factors of hepatitis C virus related liver disease in the general population: report from the Dionysos study.
    Bellentani S; Pozzato G; Saccoccio G; Crovatto M; Crocè LS; Mazzoran L; Masutti F; Cristianini G; Tiribelli C
    Gut; 1999 Jun; 44(6):874-80. PubMed ID: 10323892
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HCV-associated liver cancer without cirrhosis.
    De Mitri MS; Poussin K; Baccarini P; Pontisso P; D'Errico A; Simon N; Grigioni W; Alberti A; Beaugrand M; Pisi E
    Lancet; 1995 Feb; 345(8947):413-5. PubMed ID: 7772123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Severity of liver disease in liver transplantation recipients with hepatitis C virus infection: relationship to genotype and level of viremia.
    Zhou S; Terrault NA; Ferrell L; Hahn JA; Lau JY; Simmonds P; Roberts JP; Lake JR; Ascher NL; Wright TL
    Hepatology; 1996 Nov; 24(5):1041-6. PubMed ID: 8903372
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Genotype dependence of hepatitis C virus antibodies detectable by the first-generation enzyme-linked immunosorbent assay with C100-3 protein.
    Nagayama R; Tsuda F; Okamoto H; Wang Y; Mitsui T; Tanaka T; Miyakawa Y; Mayumi M
    J Clin Invest; 1993 Sep; 92(3):1529-33. PubMed ID: 7690782
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hepatitis C virus infection and risk of hepatocellular carcinoma among Japanese: possible role of type 1b (II) infection.
    Tanaka K; Ikematsu H; Hirohata T; Kashiwagi S
    J Natl Cancer Inst; 1996 Jun; 88(11):742-6. PubMed ID: 8637028
    [TBL] [Abstract][Full Text] [Related]  

  • 51. High prevalence of hepatitis C virus (HCV) genotype 2 in Italian patients with chronic liver disease.
    Sartori M; Andorno S; Avogadro E; Ballarè M; La Terra G; Leone F; Quaglia V; Fortina G; Aglietta M
    Ital J Gastroenterol; 1996; 28(8):452-6. PubMed ID: 9032588
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: a case-control study.
    Silini E; Bottelli R; Asti M; Bruno S; Candusso ME; Brambilla S; Bono F; Iamoni G; Tinelli C; Mondelli MU; Ideo G
    Gastroenterology; 1996 Jul; 111(1):199-205. PubMed ID: 8698200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Distribution of hepatitis C virus genotypes determined by line probe assay in patients with chronic hepatitis C seen at tertiary referral centers in the United States. Hepatitis Interventional Therapy Group.
    Lau JY; Davis GL; Prescott LE; Maertens G; Lindsay KL; Qian K; Mizokami M; Simmonds P
    Ann Intern Med; 1996 May; 124(10):868-76. PubMed ID: 8610915
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prevalence of hepatitis C virus genotypes in Italy.
    Pistello M; Maggi F; Vatteroni L; Cecconi N; Panicucci F; Bresci GP; Gambardella L; Taddei M; Bionda A; Tuoni M
    J Clin Microbiol; 1994 Jan; 32(1):232-4. PubMed ID: 8126188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Real-world Efficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir for Hepatitis C Genotype 1.
    Miyasaka A; Yoshida Y; Yoshida T; Murakami A; Abe K; Ohuchi K; Kawakami T; Watanabe D; Hoshino T; Sawara K; Takikawa Y
    Intern Med; 2018 Oct; 57(19):2807-2812. PubMed ID: 29780135
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Disease progression in Chinese patients with hepatitis C virus RNA-positive infection via blood transfusion.
    Pan YF; Zheng Y; Qin T; Feng L; Zhang Q; Ping XG; Pan YT; Wang XP; Bai L; Li HH
    Exp Ther Med; 2016 Nov; 12(5):3476-3484. PubMed ID: 27882182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Natural History of Hepatitis C.
    Lingala S; Ghany MG
    Gastroenterol Clin North Am; 2015 Dec; 44(4):717-34. PubMed ID: 26600216
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients.
    Bouzgarrou N; Hassen E; Bahri O; Gabbouj S; Mami NB; Triki H; Chouchane L
    Hepatol Int; 2011 Jun; 5(2):681-7. PubMed ID: 21484147
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Increased rate of death related to presence of viremia among hepatitis C virus antibody-positive subjects in a community-based cohort study.
    Uto H; Stuver SO; Hayashi K; Kumagai K; Sasaki F; Kanmura S; Numata M; Moriuchi A; Hasegawa S; Oketani M; Ido A; Kusumoto K; Hasuike S; Nagata K; Kohara M; Tsubouchi H
    Hepatology; 2009 Aug; 50(2):393-9. PubMed ID: 19585614
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Managing occupational risks for hepatitis C transmission in the health care setting.
    Henderson DK
    Clin Microbiol Rev; 2003 Jul; 16(3):546-68. PubMed ID: 12857782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.